← Evidence map

ArticlePloS one2026

Safety profile of camrelizumab: An analysis based on literature and database review.

Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42490631